期刊文献+

清热益气解毒汤配合西药治疗活动期系统性红斑狼疮39例 被引量:1

下载PDF
导出
摘要 目的:观察清热解毒、益气活血类中药配合西药治疗活动期系统性红斑狼疮的疗效。方法:采用扶正解毒汤(水牛角、生石膏、黄芪、玄参、知母、白术、牛膝、杜仲、陈皮等)配合西药治疗本病71例,并设对照组观察临床疗效及ESR、CRP、SCr、UTP/24h水平变化。结果:治疗组总有效率优于对照组;两组治疗后ESR、CRP、SCr、UTP/24h水平均较治疗前明显下降;治疗组治疗后ESR、CRP、SCr、UTP/24h水平明显低于同期对照组。结论:本方法对本病有清热解毒,益气活血的功效;能够明显提高临床疗效,降低不良反应的发生,达到标本兼治的目的。
作者 任彬 杨敏
出处 《陕西中医》 2009年第8期1000-1001,共2页 Shaanxi Journal of Traditional Chinese Medicine
  • 相关文献

参考文献5

二级参考文献24

  • 1Mok CC, Tong KH, To CH, et al. Taerolimus for induction therapy of diffuse proliferative lupus nephritis: an open-labeled pilot study. Kidney Int,2005,68:813-817.
  • 2Szeto CC, Kwan BC, Lai FM, et al. Tacrolimus for the treatment of systemic lupus erythematosus with pure class V nephritis. Rheumatology (Oxford) ,2008,47 : 1678-1681.
  • 3Tanaka Y,Yamamoto K,Takeuchi T,et al. A muhicenter phase Ⅰ/Ⅱ trial of rituximab for refractory systemic lupus erythematosus. Mod Rheumatol,2007,17 : 191-197.
  • 4Tamimoto Y, Horiuchi T,Tsukamoto H, et al. A dose-escalation study of rituximab for treatment of systemic lupus erythematosus and Evans'syndrome: immunological analysis of B cells,T cells and eytokines. Rheumatology ( Oxford ) ,2008,47:821-827.
  • 5Tokunaga M, Saito K, Kawabata D, et al. Efficacy of rituximab ( anti- CD20) for refractory systemic lupus erythematosus involving the central nervous system. Ann Rheum Dis,2007,66:470-475.
  • 6Dorner T, Kaufmann J, Wegener WA, et al. Initial clinical trial of epratuzumab (humanized anti-CD22 antibody ) for immunolherapy of systemic lupus erythematosus. Arthritis Res Tber,2006,8 :R74.
  • 7Ding C. Belimumab, an anti-BLyS human monoclonal antibody for potential treatment of inflammatory autoimmune diseases. Expert Opin Biol Ther,2008,8 : 1805-1814.
  • 8Furie R, Stohl W, Ginzler EM, et al. Biologic activity and safety of belimumab, a neutralizing anti-B-lymphocyte stimulator (BLyS) monoclonal antibody: a phase I trial in patients with systemic lupus erythematosus. Arthritis Res Ther,2008, 10 : R109.
  • 9Belimumab: anti-BLyS human monoclonal antibody, anti-BLyS monoclonal antibody, BmAb, human monoclonal antibody to B-lymphocyte stimulator. Drugs R D ,2008,9 : 197-202.
  • 10DallEra M, Chakravarty E, Wallace D, et at. Reduced B lymphocyte and immunoglobulin levels after atacicept treatment in patients with systemic lupus erythematosus: results of a muhicenter, phase Ib, double-blind, placebo-controlled, dose-escalating triM. Arthritis Rheum, 2007,56 : 41424150.

共引文献993

同被引文献21

引证文献1

二级引证文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部